Latest News

New compound to treat depression identified

A compound, hydroxynorketamine (HNK), has been identified by researchers that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study. Interestingly, use of HNK may also serve as a future therapeutic approach for treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, the authors note.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • How the brain 'remembers' pain

  • Researchers identify timeline for HIV replication in the brain

  • How body's good fat tissue communicates with brain

  • Crossing fingers can reduce feelings of pain

  • People who suffer migraine headaches may be at double the risk of stroke

  • Sea slug provides new way of analyzing brain data

  • Discovering age-specific brain changes in autism

  • Thin air, high altitudes cause depression in female rats

  • Testosterone needs estrogen's help to inhibit depression

  • Veterans' avoidant coping interfers with transition to university life

  •